In vitro and in vivo immunomodulatory effects of microdispersed oxidized cellulose

International Immunopharmacology

Volumn 2, Issue 10, 2002, Pages 1429-1441

  Jelínková, Markéta ^a   Briestenský, Jiří ^b   Santar, Ivan ^b   Říhová, Blanka ^a  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^b Alltracel Laboratories Ltd   (Czech Republic)

Author keywords

Bone marrow stem cells; Cell proliferation; Immunomodulator; Immunostimulation; Oxidized cellulose; Tumor necrosis factor alpha

Indexed keywords

ALUMINUM; ARGININE; CALCIUM; COBALT; GAMMA INTERFERON; GELATIN; HYDROGEN; INTERLEUKIN 4; INTERLEUKIN 6; MAGNESIUM; OXIDIZED CELLULOSE; SODIUM; TUMOR NECROSIS FACTOR ALPHA; UREA; ZINC; CELLULOSE; IMMUNOLOGICAL ADJUVANT;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; COLONY FORMING UNIT S; CONTROLLED STUDY; CYTOKINE RELEASE; DISPERSION; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; MALE; MIXED LYMPHOCYTE REACTION; MONOCYTE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SPLEEN CELL; STEM CELL; ANIMAL; C57BL MOUSE; DRUG EFFECT; LYMPHOCYTE ACTIVATION; MIXED LYMPHOCYTE CULTURE; OXIDATION REDUCTION REACTION; SECRETION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELLS, CULTURED; CELLULOSE; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036710889     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00087-5     Document Type: Article

References (47)

1. Hausen B., Morris R.E. Review of immunosuppression for lung transplantation. Novel drugs, new uses for conventional immunosuppressants, and alternative strategies. Clin. Chest Med. 18:1997;353-366.
2. Thomson A.W., Starzl T.E. New immunosuppressive drugs: mechanistic insights and potential therapeutic advances. Immunol. Rev. 136:1993;71-98.
3. Gummert J.F., Ikonen T., Morris R.E. Newer immunosuppressive drugs: a review. J. Am. Soc. Nephrol. 10:1999;1366-1380.
4. Masihi K.N. Immunomodulatory agents for prophylaxis and therapy of infections. Int. J. Antimicrob. Agents. 14:2000;181-191.
5. Chen J.T., Hasumi K. Activation of peritoneal macrophages in patients with gynecological malignancies by sizofiran and recombinant interferon-gamma. Biotherapy. 6:1993;189-194.
6. 2-targeted conjugates and combined therapy with immunomodulators. J. Control. Release. 64:2000;241-261.
7. Ooi V.E., Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr. Med. Chem. 7:2000;715-729.
8. Werner G.H., Jolles P. Immunostimulating agents: what next? A review of their present and potential medical applications. Eur. J. Biochem. 242:1996;1-19.
9. Zlotta A.R., Van Vooren J.P., Denis O., Drowart A., Daffe M., Lefevre P.et al. What are the immunologically active components of bacille Calmette-Guerin in therapy of superficial bladder cancer? Int. J. Cancer. 87:2000;844-852.
10. Hofer M., Pospíšil M. Glucan as stimulator of hematopoiesis in normal and gamma-irradiated mice. A survey of the authors' results. Int. J. Immunopharmacol. 19:1997;607-609.
11. Ross G.D., Větvička V., Yan J., Xia Y., Větvičková J. Therapeutic intervention with complement and beta-glucan in cancer. Immunopharmacology. 42:1999;61-74.
12. Morikawa K., Takeda R., Yamazaki M., Mizuno D. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-D-glucan and other immunomodulators in murine cells. Cancer Res. 45:1985;1496-1501.
13. Di Renzo L., Yefenof E., Klein E. The function of human NK cells is enhanced by beta-glucan, a ligand of CR3 (CD11b/CD18). Eur. J. Immunol. 21:1991;1755-1758.
14. Thornton B.P., Větvička V., Pitman M., Goldman R.C., Ross G.D. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol. 156:1996;1235-1246.
15. Větvička V., Thornton B.P., Ross G.D. Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J. Clin. Invest. 98:1996;50-61.
16. Větvička V., Thornton B.P., Wieman T.J., Ross G.D. Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18). J. Immunol. 159:1997;599-605.
17. Wakshull E., Brunke-Reese D., Lindermuth J., Fisette L., Nathans R.S., Crowley J.J.et al. PGG-glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor in human PMN: evidence for a glycosphingolipid beta-(1,3)-glucan receptor. Immunopharmacology. 41:1999;89-107.
18. Patchen M.L., Vaudrain T., Correira H., Martin T., Reese D. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan. Exp. Hematol. 26:1998;1247-1254.
19. Adams D.S., Pero S.C., Petro J.B., Nathans R., Mackin W.M., Wakshull E. PGG-Glucan activates NF-kappaB-like and NF-IL-6-like transcription factor complexes in a murine monocytic cell line. J. Leukoc. Biol. 62:1997;865-873.
20. Stilwell R.L., Marks M.G., Saferstein L., Wiseman D.M. Oxidized cellulose: chemistry, processing and medical applications. Dombs A., Kost J., Wiseman D. Handbook of biodegradable polymers. 1997;291 Harwood Academic Publishers, Amsterdam.
21. Haney A.F., Doty E. Comparison of the peritoneal cells elicited by oxidized regenerated cellulose (Interceed) and expanded polytetrafluoroethylene (Gore-Tex Surgical Membrane) in a murine model. Am. J. Obstet. Gynecol. 166:1992;1137-1146.
22. Reddy S., Santanam N., Reddy P.P., Rock J.A., Murphy A.A., Parthasarathy S. Interaction of Interceed oxidized regenerated cellulose with macrophages: a potential mechanism by which Interceed may prevent adhesions. Am. J. Obstet. Gynecol. 177:1997;1315-1320.
23. Ryan C.K., Sax H.C. Evaluation of a carboxymethylcellulose sponge for prevention of postoperative adhesions. Am. J. Surg. 169:1995;154-159.
24. Sandhu G.S., Elexpuru Camiruaga J.A., Buckley S. Oxidized cellulose (Surgicel) granulomata mimicking tumour recurrence. Br. J. Neurosurg. 10:1996;617-619.
25. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
26. Li L., Sad S., Kagi D., Mosmann T.R. CD8Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions. J. Immunol. 158:1997;4152-4161.
27. Liew F.Y. Regulation of delayed type hypersensitivity to pathogens and alloantigens. Immunol. Today. 3:1982;18-23.
28. Kundig T.M., Althage A., Hengartner H., Zinkernagel R.M. Skin test to assess virus-specific cytotoxic T-cell activity. Proc. Natl. Acad. Sci. U. S. A. 89:1992;7757-7761.
29. J. Briestenský, F. Kiss, I. Santar, Microdispersed polyanhydroglucuronic acid and salts thereof, Patent GB 2335921, 2000.
30. Till J.E., McCulloch E.A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14:1961;213-222.
31. Říhová B., Říha I. Genetic regulation of antibody response to sheep red blood cells: linkage to H-2 complex. Am. J. Reprod. Immunol. 1:1981;168-173.
32. Říhová B., Říha I., Rossmann P., Větvička V. Low IgG response of the mouse strain C57BL/10ScSn after immunization with protein antigens. Folia Microbiol. (Prague). 30:1985;295-301.
33. Říhová B., Větvička V. Low IgG responsiveness in C57BL mice. Říhová B., Větvička V. Immunological disorders in mice. 1991;153-232 CRC Press, Boca Raton, FL.
34. Šírová M., Říha I., Říhová B. Limited T helper cell activity in C57BL/10 (B10) mice with inherited low IgG responsiveness. Scand. J. Immunol. 44:1996;453-460.
35. Gomaa K., Kraus J., Rosskopf F., Roper H., Franz G. Antitumour and immunological activity of a beta 1-3/1-6 glucan from Glomerella cingulata. J. Cancer Res. Clin. Oncol. 118:1992;136-140.
36. Espevik T., Otterlei M., Skjak Braek G., Ryan L., Wright S.D., Sundan A. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur. J. Immunol. 23:1993;255-261.
37. Hamann L., El Samalouti V., Ulmer A.J., Flad H.D., Rietschel E.T. Components of gut bacteria as immunomodulators. Int. J. Food Microbiol. 41:1998;141-154.
38. Šandula J., Machová E., Hříbalová V. Mitogenic activity of particulate yeast beta-(1→3)-D-glucan and its water-soluble derivatives. Int. J. Biol. Macromol. 17:1995;323-326.
39. Otterlei M., Sundan A., Skjak Braek G., Ryan L., Smidsrod O., Espevik T. Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction. Infect. Immun. 61:1993;1917-1925.
40. Říhová B. Biocompatibility of biomaterials: hemocompatibility, immunocompatibility and biocompatibility of solid polymeric materials and soluble targetable polymeric carriers. Adv. Drug Deliv. Rev. 21:1996;157-176.
41. Ohno N., Hashimoto T., Adachi Y., Yadomae T. Conformation dependency of nitric oxide synthesis of murine peritoneal macrophages by beta-glucans in vitro. Immunol. Lett. 53:1996;157-163.
42. Luger A., Kovarik J., Stummvoll H.K., Urbanska A., Luger T.A. Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int. 32:1987;84-88.
43. Liu F., Ooi V.E., Fung M.C. Analysis of immunomodulating cytokine mRNAs in the mouse induced by mushroom polysaccharides. Life Sci. 64:1999;1005-1011.
44. Hoffman O.A., Olson E.J., Limper A.H. Fungal beta-glucans modulate macrophage release of tumor necrosis factor-alpha in response to bacterial lipopolysaccharide. Immunol. Lett. 37:1993;19-25.
45. Williams D.L., Pretus H.A., McNamee R.B., Jones E.L., Ensley H.E., Browder I.W. Development of a water-soluble, sulfated (1→3)-beta-D-glucan biological response modifier derived from Saccharomyces cerevisiae. Carbohydr. Res. 235:1992;247-257.
46. Tsuchiya Y., Matsutani M., Inoue M., Sato S., Asano T., Yajima M. Effect of a glucan, sizofiran, on natural-killer activity of 5-fluorouracil-treated murine bone marrow cells. Cancer Immunol. Immunother. 34:1991;17-23.
47. Cross G.G., Jennings H.J., Whitfield D.M., Penney C.L., Zacharie B., Gagnon L. Immunostimulant oxidized beta-glucan conjugates. Int. Immunopharmacol. 1:2001;539-550.